Skip to content

NUVBNUVATION BIO INC

CUSIP 67080N101 · common stock

5 tracked investors held NUVATION BIO INC (NUVB) at the end of Q3 2026, worth $22.2M in total. The largest holder was Stanley Druckenmiller, with 0.3% of its portfolio. Torray Funds opened a new position this quarter.

Holders · Q3 2026
5
New holders
1
Value held
$22.2M
Quarter-end price (est.)
$5.60

Investors holding NUVB · Q3 2026

InvestorWeightSharesValueChange
Stanley Druckenmiller
Duquesne Family Office LLC
0.28%2,269,900$12.7MREDUCE-50.0%
David Abrams
Abrams Capital Management, L.P.
0.15%1,270,504$7.1MHOLD
Torray Funds
Torray Investment Partners LLC
0.20%274,814$1.5MNEW
Joel Greenblatt
Gotham Asset Management, LLC
0.00%115,480$646.7KREDUCE-36.6%
David Einhorn
DME Capital Management, LP
0.01%34,995$196KHOLD

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026510$22.2M$5.60
Q2 2026411$34.2M$5.68
Q1 2026421$25.3M$4.29
Q4 2025300$34.7M$8.96
Q1 2023001$0—
Q4 2022100$9.2M$1.92
Q3 2022100$23.3M$2.24
Q2 2022100$33.8M$3.24
Q1 2022100$54.9M$5.26
Q4 2021100$73M$8.46
Q3 2021100$85.4M$9.90
Q2 2021100$77.1M$8.95
Q1 2021110$82.4M$9.55